Latest news for Katitas Co (OTC:KTITF) Stock

Katitas Co Ltd operates in the housing market in Japan. The company is engaged in the business activities of purchase, renovation, and sale of secondhand houses.

Katitas Co Ltd

Guggenheim analyst John Difucci maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Buy and raises the price target from $185 to $200.

News

Price Target

Analyst Ratings

ORCL

Guggenheim Maintains Buy on Oracle, Raises Price Target to $200

Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) shares are trading higher premarket Friday. Exxon Mobil inked a Project Framework Agreement&nbsp;with Mitsubishi Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MSBHF#OTC">MSBHF</a>) for <a target="_blank" href="https://www.mitsubishicorp.com/jp/en/pr/archive/2024/html/0000054472.html" rel="noreferrer noopener">participation</a> in its Baytown, Texas facility.
Under the terms of the agreement, the companies will advance talks regarding Mitsubishi&#8217;s offtake of low-carbon ammonia and equity participation in the project.&nbsp;
The facility is expected to produce low-carbon hydrogen and ammonia by capturing 98% of CO2.
The facility is set to become the world&#8217;s largest of its kind, capable of producing up to 1 billion cubic feet (bcf) of low-carbon hydrogen daily, with 98% CO2 removal, and over 1 million tons of low-carbon ammonia annually.
A final investment decision is expected in 2025, with startup projected for 2029.
ExxonMobil Low Carbon Hydrogen and ammonia will offer customers a reliable, low-carbon energy source, adhering to high operational standards.
Mitsubishi plans to convert part of its LPG terminal into an ammonia terminal for transshipment, supplying low-carbon ammonia to industries such as power, automotive, and chemical in Japan&#8217;s Shikoku and Chugoku regions.
Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40772105/exxon-passes-on-10b-namibian-oil-field-report" rel="noreferrer noopener">Exxon Passes On $10B Namibian Oil Field: Report</a>
Mitsubishi has also created a &#8220;Council for Utilizing Namikata Terminal as a Hub for Introducing Fuel Ammonia,&#8221; aiming to handle 1 million tons of low-carbon ammonia annually by 2030.
Masaru Saito Group CEO, Environmental Energy Group of Mitsubishi Corporation stated, &#8220;We are excited to be closely collaborating with ExxonMobil to develop low-carbon hydrogen and ammonia supply chains that will bridge the United States and Japan.&#8221;
&#8220;We are also working with Idemitsu Kosan Co.,Ltd., which is developing an ammonia hub near ours and intends to participate in ExxonMobil&#8217;s hydrogen facility with us.&nbsp;Together, we will lead this joint initiative to&nbsp;assist in the acceleration of the hard-to-abate sectors&#8217; transition to clean energy.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40814667/exxon-other-us-oil-majors-brace-for-tropical-storm-francine-report" rel="noreferrer noopener">Exxon, Other US Oil Majors Brace For Tropical Storm Francine: Report</a>
Investors can gain exposure to XOM via&nbsp;EA Series Trust Strive U.S. Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRLL#NYSE">DRLL</a>) and&nbsp;Westwood Salient Enhanced Energy Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEEI#NASDAQ">WEEI</a>).
Price Action: XOM shares are up 0.46% at $111.74 premarket at the last check Friday.
Photo: Del Henderson Jr. via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/24/09/40822108/hurricane-francine-approaches-louisiana-coast-may-become-category-2-storm" target="_blank" rel="noreferrer noopener">Hurricane Francine Approaches Louisiana Coast With Category 2 Storm Potential, Local Oil Refineries Cut Production</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

DRLL

MSBHF

WEEI

Exxon, Mitsubishi Join Forces For Low-Carbon Hydrogen Project

The United Arab Emirates (UAE) is reportedly set to reignite a multi-billion dollar deal with the U.S. for F-35 warplanes and armed drones if Donald Trump secures a second term as president, according to insiders.
What Happened: The UAE has long desired the advanced fighter jet equipped with stealth technology that allows it to evade enemy detection. The U.S. approval of the transfer would make the UAE the second Middle East state after Israel to operate F-35 fighters, Reuters reported on Friday. 
Trump had approved the $23 billion deal, which included MQ-9 Reaper drones and munitions, after the UAE established ties with Israel in 2020 under an accord brokered by his administration. However, the UAE suspended talks by the end of 2021, unable to agree terms with the Biden administration.
Three sources stated that if Trump was re-elected, the UAE would seek to resume talks, asking a new Trump administration to fulfil the original agreement. One of the sources said the UAE would ask a new Trump administration to &#8220;honour&#8221; the 2021 deal.
See Also: <a href="https://www.benzinga.com/news/24/09/40807096/melania-trump-says-the-attempt-to-end-her-husbands-life-was-a-horrible-distressing-experience-we-nee?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Melania Trump Says The Attempt To End Her Husband&#8217;s Life Was A &#8216;Horrible, Distressing Experience&#8217;: We Need To Uncover The Truth</a>
The UAE is one of Washington&#8217;s most important security partners in the Middle East. Its military has fought alongside the U.S. in several campaigns, including the war in Afghanistan, and American soldiers are stationed in Abu Dhabi.
Trump&#8217;s campaign&#8217;s national press secretary Karoline Leavitt said in a statement that a second Trump presidency would &#8220;once again deliver peace through strength to rebuild and expand the peace coalition he built in his first term to create long-term safety and security in the Middle East and around the world.&#8221;
Why It Matters: The F-35 deal has been a point of contention between the U.S. and UAE. In 2021, the Biden administration had urged the <a href="https://www.benzinga.com/news/21/06/21532782/us-urges-uae-to-replace-adversary-huawei-triggering-doubts-on-lockheed-martins-f-35-jet-drone-sales">UAE to replace Huawei Technologies Co </a>from its telecommunications network, which further jeopardized UAE&#8217;s purchase of $23 billion in Lockheed Martin Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) F-35 jets and drones.
The U.S. requested the UAE to remove Huawei equipment from its networks within the next four years before the F-35&#8217;s proposed delivery in 2026 or 2027. However, the UAE officials said they need more time and sought an affordable alternative.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40815343/not-a-slam-dunk-for-harris-but-the-chances-of-a-trump-victory-have-slipped-investors-markets-adjust?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Not A Slam Dunk For Harris, But The Chances Of A Trump Victory Have Slipped:&#8217; Investors, Markets Adjust Positions After Presidential Debate</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Global

General

UAE Plans To Reportedly Push Trump On F-35 Deal If He Returns To White House

BMO Capital analyst Ari Klein maintains American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) with a Outperform and raises the price target from $246 to $260.

BMO Capital Maintains Outperform on American Tower, Raises Price Target to $260

Kaixin Holdings ("Kaixin" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>), a leading new energy vehicle manufacturer and sales platform in China, today announced that it received a letter dated September 12, 2024 from the Nasdaq Hearings Panel ("Panel"), indicating that the Panel has determined to grant the Company a temporary exception to regain compliance with The Nasdaq Stock Market LLC's Listing Rule 5550(a)(2) (the "Bid Price Rule") by December 13, 2024. The Company is scheduled to hold an extraordinary general meeting on October 1, 2024 to obtain shareholders' approval for a reverse stock split. The Company aims to effectuate a reverse stock split by November 30, 2024, and to regain compliance with the Bid Price Rule by December 13, 2024. &nbsp;
The temporary exception granted to the Company is subject to the following milestones. In the event the Company fails to regain compliance with the Bid Price Rule by December 13, 2024, its securities will be delisted.
<ol>
<li>On or before October 1, 2024, the Company shall obtain shareholders approval for a reverse stock split at a ratio that satisfies the minimum requirement in the Bid Price Rule;</li>
<li>On or before November 30, 2024, the Company shall effect a reverse stock split and, thereafter, maintain a $1 closing bid price for a minimum of ten consecutive business days;</li>
<li>On or before December 13, 2024, the Company shall have demonstrated compliance with the Bid Price Rule, by evidencing a closing bid price of $1 or more per share for a minimum of ten consecutive trading sessions.</li>
</ol>

Government

Regulations

Stock Split

KXIN

Kaixin Holdings Granted Nasdaq Extension to Regain Compliance, Plans Reverse Stock Split

Bernstein analyst Mark Moerdler maintains Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with a Outperform and lowers the price target from $660 to $644.

ADBE

Bernstein Maintains Outperform on Adobe, Lowers Price Target to $644

The Russian President, Vladimir Putin, issued a stern warning to the West on Thursday, stating that the use of Western-made long-range missiles by Ukraine against Russia could lead to a direct military confrontation between Russia and the West.
What Happened: Ukraine&#8217;s President, Volodymyr Zelenskyy, has been lobbying for Western allies to permit Ukraine to deploy U.S. ATACMS and British Storm Shadows missiles against Russia, in a bid to limit Moscow&#8217;s attack capabilities, Reuters reported on Friday.
Putin argued that such an action would directly implicate the countries providing these missiles to Ukraine in the ongoing conflict, as the programming of the missiles&#8217; flight paths and satellite targeting data would necessitate the involvement of NATO military personnel.
&#8220;This will mean that NATO countries, the U.S. and European countries are at war with Russia,&#8221; Putin said, as reported by NBC.
See Also: <a href="https://www.benzinga.com/news/24/09/40808499/trump-vs-harris-debates-results-are-in-flash-poll-shows-resounding-majority-pick-vice-president-as-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs. Harris Debate&#8217;s Results Are In: Flash Poll Shows Resounding Majority Pick Vice President As Winner, But She Still Trails GOP Rival By 20 Points On This Issue</a>
Russia, the world&#8217;s largest nuclear power, is currently revising its nuclear doctrine and considering curbs on major commodity exports. It is also conducting major naval exercises with China. The West is deliberating whether to allow Ukraine to use its long-range weapons against Russia in response to what it perceives as an escalation of the war by Moscow.
Why It Matters: Putin&#8217;s remarks point to a potential escalation in the conflict, with the implication that the participation of NATO countries in the war could drastically alter the conflict&#8217;s dynamics. He did not elaborate on what actions Russia might take in response, but he has previously alluded to the possibility of arming the West&#8217;s adversaries with Russian weapons to target Western interests.
Earlier in June, President Joe Biden had eased restrictions that<a href="https://www.benzinga.com/government/24/06/39438195/ukraine-has-right-to-fire-back-at-russia-with-us-provided-munitions-as-kremlin-seeks-talks-with-whit"> prevented Ukraine's military</a> from sending U.S.-provided munitions into Russia in an effort to prevent further escalation of the war.
Moreover, a leading Russian foreign policy hawk, Sergei Karaganov, recently advocated for a <a href="https://www.benzinga.com/news/24/09/40829787/top-russian-foreign-policy-hawk-pushes-for-bold-nuclear-response-to-western-support-in-ukraine-time">more aggressive nuclear stance</a> in response to Western support for Ukraine, suggesting that Russia should openly express its readiness to use nuclear weapons against countries supporting NATO aggression in Ukraine.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments.&nbsp;<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo by Salma Bashir Motiwala on Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Russian President Says Ukraine's Use Of Long-Range Missiles Would Signal That US And NATO 'Are At War With Russia'

<div>The collaboration plans to evaluate the combination of&nbsp;Marengo&#39;s first-in-class TCR V&beta;&nbsp;selective dual T cell agonist, STAR0602 (Invikafusp alfa), with Trodelvy (sacituzumab govitecan-hziy) Gilead&#39;s Trop-2 directed ADC in a new multi-center Phase I/II clinical study (START-002).</div>
<div>
The planned combination trial, sponsored by Marengo, is expected to commence soon. This study will evaluate the safety, tolerability, and preliminary efficacy of STAR0602 (Invikafusp alfa) in combination with Trodelvy in patients with metastatic TNBC or metastatic HR+/HER2- breast cancer, aiming to explore a novel therapeutic strategy that could offer new treatment options for patients.
Under the clinical study collaboration and supply agreement, Gilead will provide Trodelvy to Marengo, who will conduct and sponsor the combination study. Marengo and Gilead will retain all development and commercial rights to their respective compounds, including as monotherapy or as combination therapies.
</div>

GILD

Marengo Therapeutics Enters Clinical Study Collaboration And Supply Agreement With Gilead Sciences

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>), a leading clinical-stage precision oncology company, today announced the Company will share new data from Module 1 of its ongoing Phase 1/2 TRESR clinical trial during an oral presentation on September 14 at the European Society for Medical Oncology Congress (ESMO), held in Barcelona, Spain.
TRESR (NCT04497116) is a first-in-human, multi-center, open-label Phase 1/2 dose-escalation and expansion study designed to establish the recommended Phase 2 dose (RP2D) and schedule. The study evaluated safety, pharmacokinetics and identify preliminary anti-tumor activity associated with camonsertib monotherapy in patients with solid tumors (Module 1).

RPTX

Repare Therapeutics to Present Phase 1/2 Cancer Trial Data at Barcelona Conference

IMNM

Immunome To Present Poster With Updated Results From RINGSIDE Phase 2 Clinical Trial Of AL102 At ESMO

From pouring drinks behind a bar to becoming a billionaire entrepreneur,&nbsp;Mark Cuban&#8216;s journey to success is nothing short of inspiring. 
What Happened: On Thursday, the Dallas Mavericks part-owner took to X, formerly Twitter, and responded to a user who shared a throwback picture of his, highlighting Cuban&#8217;s transformation from a bartender to a successful entrepreneur.
In response, Cuban&nbsp;said, &#8220;I had one piece&nbsp;of art in the entire&nbsp;place. It's there in the&nbsp;corner — Poverty S&#x2A;&#x2A;ks&#8221;.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/09/40767860/mark-cuban-praises-elon-musks-ai-chatbot-grok-for-answering-kamala-harris-pov-on-immigration-i-think?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Praises Elon Musk&#8217;s AI Chatbot Grok For Answering Kamala Harris&#8217; POV On Immigration: &#8216;I Think It&#8217;s Accurate&#8217;</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I had one piece of "art" in the entire place. It's there in the corner. "Poverty Sucks" <a href="https://t.co/cIDfARR76P">https://t.co/cIDfARR76P</a>
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1833902502485631203?ref_src=twsrc%5Etfw">September 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Prior to his fame on &#8220;Shark Tank,&#8221; Cuban began&nbsp;his career as a bartender in Dallas at a place called Elan. However, he quickly realized that he wasn&#8217;t good at working for people.
After a stint as a software salesman, which ended with him being fired, Cuban started his own company, MicroSolutions. He later co-founded Broadcast.com, which&nbsp;was sold to Yahoo! in&nbsp;1999 for a whopping $5.7 billion.
Today, Cuban is not just a billionaire with an estimated net worth of $7.59 billion, according to the Bloomberg Billionaire <a href="https://www.bloomberg.com/billionaires/">Index</a>, but also a significant figure in the realms of business and sports.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Previously, Cuban shared a piece of <a href="https://www.benzinga.com/general/entertainment/24/09/40741507/mark-cuban-shares-advice-he-would-give-to-his-younger-self-i-wish-someone-told-me">advice he would give</a> to his younger self. &#8220;I wish someone would have told me to be nicer,&#8221; he said.
Despite his success, Cuban has not shied away from <a href="https://www.benzinga.com/news/24/09/40849505/mark-cuban-says-he-truly-does-not-hate-trump-but-calls-him-a-lousy-president-if-he-wasnt-running">expressing his political views</a>.
The billionaire has been making headlines for his open criticism of former President Donald Trump&#8217;s policies while endorsing Vice President Kamala Harris in the upcoming 2024 U.S. Presidential election.
Cuban has also <a href="https://www.benzinga.com/general/social-media/24/08/40381505/mark-cuban-on-elon-musks-global-reach-through-x-the-most-influential-man-in-the-world">been locking horns</a> with Tesla and SpaceX CEO Elon Musk. He has been <a href="https://www.benzinga.com/news/23/11/35926664/mark-cuban-challenges-elon-musk-on-twitter-ad-efficacy-thats-the-real-world-today">criticizing Musk since</a> the Tesla CEO acquired Twitter for $44 billion in October 2022.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/government/24/09/40794781/gop-lawmaker-defends-google-amid-antitrust-trial-penalize-them-for-trying-to-be-good-business-thats?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">GOP Lawmaker Defends Google Amid Antitrust Trial: &#8216;Penalize Them For Trying To Be Good Business? That&#8217;s Insane&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Mark Cuban Was Once Tending A Bar In Dallas But Quickly Realized He Wasn't Great At Working For People: 'I Had One Piece Of Art In The Entire Place… Poverty S**ks'

The&nbsp;trial did not meet the primary endpoint of a statistically significant reduction in all-cause hospitalization or death through Day 29 in the monotherapy cohort of 2,221 high-risk patients with mild to moderate COVID-19. In SUNRISE-3, bemnifosbuvir was generally safe and well tolerated.

AVIR

Atea Pharmaceuticals Updates On Global Phase 3 SUNRISE-3 Trial On Bemnifosbuvir For Treatment Of COVID-19; Says Trial Did Not Meet Primary Endpoint

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) with a Buy and maintains $50 price target.

Reiteration

GMAB

HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $50 Price Target

Piper Sandler analyst Edward Tenthoff maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Overweight and lowers the price target from $157 to $115.

MRNA

Piper Sandler Maintains Overweight on Moderna, Lowers Price Target to $115

HC Wainwright &amp; Co. analyst Ed Arce reiterates Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) with a Buy and maintains $38 price target.

PLRX

HC Wainwright & Co. Reiterates Buy on Pliant Therapeutics, Maintains $38 Price Target

Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Permian Resources</h3>
<ul>
<li>The Trade: Permian Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) Director William J Quinn <a href="https://www.benzinga.com/quote/ONEW/analyst-ratings">acquired a total of 312,429 shares at</a> an average price of $12.79. To acquire these shares, it cost around $3.99 million.</li>
<li>What's Happening: On Sept. 12, JP Morgan analyst Arun Jayaram maintained Permian Resources with an Overweight and lowered the price target from $20 to $17..</li>
<li>What Permian Resources Does: Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets.</li>
</ul>
<h3 class="wp-block-heading">PENN Entertainment</h3>
<ul>
<li>The Trade: PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) Director David A Handler acquired a total of 10,000 shares at an average price of $17.51. To acquire these shares, it cost around $175,100.</li>
<li>What's Happening: On Aug. 8, PENN Entertainment posted upbeat quarterly earnings.</li>
<li>What PENN Entertainment Does: Penn Entertainment&#8217;s origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar.</li>
</ul>
<h3 class="wp-block-heading">Aptiv</h3>
<ul>
<li>The Trade: Aptiv PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) CEO and Chairman Kevin P Clark <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 29,770 shares</a> at an average price of $65.45. To acquire these shares, it cost around $1.95 million.</li>
<li>What's Happening: On Sept. 10, Deutsche Bank analyst Edison Yu reinstated Aptiv with a Hold and announced a $74 price target.</li>
<li>What Aptiv Does: Aptiv&#8217;s signal and power solutions segment supplies components and systems that make up a vehicle&#8217;s electrical system, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40831857/paypal-is-a-buy-jim-cramer-says-as-for-rivian-let-it-percolate">PayPal Is A Buy, Jim Cramer Says: As For Rivian? &#8216;Let It Percolate&#8217;</a></li>
</ul>

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

APTV

PENN

$4M Bet On This Energy Stock? Check Out These 3 Stocks Executives Are Buying

General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) will release earnings results for its first quarter, before the <a href="https://www.benzinga.com/quote/GIS/earnings">opening bell on Thursday, Sept. 18</a>.
Analysts expect the Minneapolis, Minnesota-based company to report quarterly earnings at $1.06 per share, down from $1.09 per share in the year-ago period. General Mills is projected to post revenue of $4.79 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
On Sept. 12, General Mills announced agreements to sell its North American Yogurt business to Lactalis and Sodiaal.
General Mills shares fell 0.2% to close at $73.01 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TCOM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Mizuho analyst John Baumgartner maintained a Neutral rating and cut the price target from $70 to $62 on July 3. This analyst has an accuracy rate of 68%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59009b590bd9910001e5f2a5/david-palmer">Evercore ISI Group analyst David Palmer</a> maintained an In-Line rating and slashed the price target from $76 to $72 on June 28. This analyst has an accuracy rate of 65%.</li>
<li>B of A Securities analyst Bryan Spillane maintained a Neutral rating and slashed the price target from $70 to $68 on June 27. This analyst has an accuracy rate of 66%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59a574bdca17380001c65867/chris-carey">Wells Fargo analyst Chris Carey</a> maintained an Equal-Weight rating and cut the price target from $70 to $67 on June 27. This analyst has an accuracy rate of 63%.</li>
<li>RBC Capital analyst Nik Modi reiterated a Sector Perform rating with a price target of $70 on June 27. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying GIS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="520" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12185203/image-103-1024x520.png" alt="" class="wp-image-545754" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12185203/image-103-1024x520.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12185203/image-103-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12185203/image-103-768x390.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/12185203/image-103.png 1322w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40829998/upstart-insulet-and-2-other-stocks-executives-are-selling">Upstart, Insulet And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Earnings

General Mills Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

ANIP

Ani Pharmaceuticals Launches Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution

Biotech

Health Care

Legal

Emergent Biosolutions Has Entered Into An Agreement To Resolve The Previously Disclosed Securities Class Action Litigation, Emergent Will Pay $40M To Settle Claims

Oakmark International Small Cap Fund: Q3 2023 And FY-End Commentary

Oakmark International Small Cap Fund: Q2 2024 Commentary

KATITAS CO (JP:8919) has released an update. KATITAS Co., Ltd. has finalized the sale of treasury stocks allocated for restricted stock compensatio...

KATITAS Completes Restricted Stock Compensation Sale

KATITAS CO (JP:8919) has released an update. KATITAS Co., Ltd. reported a slight decrease in net sales by 1.3% and a dip in profit attributable to ...

KATITAS Co. Shows Mixed Q1 Results, Eyes Growth

KATITAS CO (JP:8919) has released an update. KATITAS Co., Ltd. emphasizes swift management decisions and corporate governance for increased corpora...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Katitas Co

News

Latest news for Katitas Co (OTC:KTITF) Stock